Socioeconomic Disparities Seen for Timing of Preoperative Hemodialysis
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 2, 2023 -- There are significant age-, sex-, race-, and social deprivation-related disparities in the timing of preoperative hemodialysis for patients with end-stage kidney disease (ESKD), according to a research letter published online July 28 in JAMA Network Open.
Vikram Fielding-Singh, M.D., J.D., from the Stanford University School of Medicine in California, and colleagues used data from the United States Renal Data System to identify 338,391 adults with ESKD receiving hemodialysis undergoing surgical procedures (1.12 million procedures) from Jan. 1, 2011, to Sept. 30, 2018.
The researchers found that 81.9 percent of procedures had a shorter (zero- or one-day) interval between the last outpatient hemodialysis treatment and surgery, while 18.1 percent had a longer (two- or three-day) interval. Older patients had longer hemodialysis-surgery intervals (age 60 to 79 years: adjusted odds ratio [aOR], 1.08; age 80 years or older: aOR, 1.13) versus patients aged 18 to 39 years. Significantly longer intervals between hemodialysis and surgery were seen for women (versus men: aOR, 1.06), non-Hispanic Black race (versus non-Hispanic White: aOR, 1.17), and each increasing decile of social deprivation index (aOR, 1.02).
"Given that a longer interval between preoperative hemodialysis and surgical procedures is associated with higher postoperative mortality, these findings are concerning and identify a possible avenue to improve equity in surgical outcomes for patients with ESKD," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
WEDNESDAY, June 5, 2024 -- Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among...
Odds of Death Lower With Surgery for Hip Fracture in Patients With Dementia
MONDAY, June 3, 2024 -- For community-dwelling patients with dementia and fracture of the femoral head and neck, the odds of death are lower for those treated surgically...
Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income
FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.